Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancerMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2003
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumJohn B Welsh, Lisa M Sapinoso, Suzanne G Kern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancerViola A Heinzelmann-Schwarz, Margaret Gardiner-Garden, Susan M Henshall, et al.
The Journal of Clinical Investigation|August 8, 2013
Transcription factor ATF3 links host adaptive response to breast cancer metastasisChris C Wolford, Stephen J McConoughey, Swati P Jalgaonkar, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Cancer Research|July 23, 2003
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapseSusan M Henshall, Daniel E H Afar, Jordan Hiller, et al.
Cancer Research|March 23, 2005
The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcomeAsne R Bauskin, David A Brown, Simon Junankar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkersJames Devaney, Clare Stirzaker, Wenjia Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Pageof 16